← Leaderboards
Victor J Hruby
University Of Arizona
$15,253,987
Attributed
$17,465,035
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$33,700,182 · 15
By mechanism
P01$19,425,642 · 9
R01$14,269,540 · 5
R13$5,000 · 1
Top collaborators
- Minying Cai5 shared
- Frank Porreca5 shared
- David L Morse4 shared
- Robert J Gillies3 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Minying Cai$590,180
- Henry I Yamamura$2,942,800
Others in their field
Top investigators on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Keith W Miller · Massachusetts General Hospital$35,506,092
- Ian A Wilson · Scripps Research Institute, The$35,392,112
- Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
- Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
- Helen M Berman · Rutgers University New Brunswick$32,076,400
Research focus
LigandsDesignAgonistReceptorAnalgesicsPainIn VivoPainful NeuropathyPeptidomimeticsLeadPeptidesAffinityBiologicalPharmaceutical PreparationsAdverse EffectsBaseIn VitroChronic PainPain ManagementPharmacologyOpioidPropertyProgramsDrug Seeking Behavior
Grant awards (88)
Design of Novel Multivalent Ligands with Unique Biological Activity Profiles for Treatment of Prolonged and Neuropathic Pain without Toxicities$76,336
P01 · FY2021 · DA · contact PI
New Modalities for the Treatment of Pain and Drug Abuse$529,210
P01 · FY2020 · DA
Design of Novel Multivalent Ligands with Unique Biological Activity Profiles for Treatment of Prolonged and Neuropathic Pain without Toxicities$76,336
P01 · FY2020 · DA · contact PI
New Modalities for the Treatment of Pain and Drug Abuse$532,410
P01 · FY2019 · DA
New Modalities for the Treatment of Pain and Drug Abuse$545,210
P01 · FY2018 · DA
New Modalities for the Treatment of Pain and Drug Abuse$357,131
P01 · FY2018 · DA
Design of Novel Multivalent Ligands with Unique Biological Activity Profiles for Treatment of Prolonged and Neuropathic Pain without Toxicities$92,336
P01 · FY2018 · DA · contact PI
New Modalities for the Treatment of Pain and Drug Abuse$537,713
P01 · FY2017 · DA
Designing Novel Melanotropins for New Applications for the Melanocortin System$279,172
R01 · FY2017 · GM · contact PI
Design of Novel Multivalent Ligands with Unique Biological Activity Profiles for Treatment of Prolonged and Neuropathic Pain without Toxicities$56,489
P01 · FY2017 · DA · contact PI
Designing Novel Melanotropins for New Applications for the Melanocortin System$279,424
R01 · FY2016 · GM · contact PI
Novel Non-Peptide Opioid Ligands for Pain$469,079
R01 · FY2015 · DA · contact PI
Designing Novel Melanotropins for New Applications for the Melanocortin System$279,670
R01 · FY2015 · GM · contact PI
NEW MODALITIES FOR TREATMENT OF PAIN AND DRUG ABUSE$99,990
P01 · FY2015 · DA · contact PI
Supplement for "Designing Novel Melanotropins for New Applications for the Melanocortin System"$62,185
R01 · FY2015 · GM · contact PI
Novel Non-Peptide Opioid Ligands for Pain$509,990
R01 · FY2014 · DA · contact PI
Designing Novel Melanotropins for New Applications for the Melanocortin System$279,908
R01 · FY2014 · GM · contact PI
Novel Non-Peptide Opioid Ligands for Pain$11,575
R01 · FY2014 · DA · contact PI
NEW MODALITIES FOR TREATMENT OF PAIN AND DRUG ABUSE$1,124,728
P01 · FY2013 · DA · contact PI
Novel Non-Peptide Opioid Ligands for Pain$458,100
R01 · FY2013 · DA · contact PI
DESIGN OF NOVEL LIGANDS WITH UNIQUE BIOLOGICAL PROFILES FOR NEUROPATHIC PAIN AND$189,957
P01 · FY2013 · DA · contact PI
SYNTHESIS CORE$157,430
P01 · FY2013 · DA · contact PI
ADMINISTRATIVE CORE$74,811
P01 · FY2013 · DA · contact PI
Novel Non-Peptide Opioid Ligands for Pain$24,593
R01 · FY2013 · DA · contact PI
NEW MODALITIES FOR TREATMENT OF PAIN AND DRUG ABUSE$1,186,822
P01 · FY2012 · DA · contact PI
Multimeric Ligands for Targeting Melanoma$600,715
R01 · FY2012 · CA
Novel Non-Peptide Opioid Ligands for Pain$486,733
R01 · FY2012 · DA · contact PI
DESIGN OF NOVEL LIGANDS WITH UNIQUE BIOLOGICAL PROFILES FOR NEUROPATHIC PAIN AND$197,910
P01 · FY2012 · DA · contact PI
SYNTHESIS CORE$165,359
P01 · FY2012 · DA · contact PI
Multimeric Ligands for Targeting Melanoma$86,469
R01 · FY2012 · CA
ADMINISTRATIVE CORE$82,681
P01 · FY2012 · DA · contact PI
NEW MODALITIES FOR TREATMENT OF PAIN AND DRUG ABUSE$1,195,221
P01 · FY2011 · DA · contact PI
Multimeric Ligands for Targeting Melanoma$602,202
R01 · FY2011 · CA
Novel Non-Peptide Opioid Ligands for Pain$496,467
R01 · FY2011 · DA · contact PI
DESIGN OF NOVEL LIGANDS WITH UNIQUE BIOLOGICAL PROFILES FOR NEUROPATHIC PAIN AND$205,712
P01 · FY2011 · DA · contact PI
SYNTHESIS CORE$165,459
P01 · FY2011 · DA · contact PI
ADMINISTRATIVE CORE$82,730
P01 · FY2011 · DA · contact PI
Multimeric Ligands for Targeting Melanoma$73,046
R01 · FY2011 · CA
NEW MODALITIES FOR TREATMENT OF PAIN AND DRUG ABUSE$1,225,040
P01 · FY2010 · DA · contact PI
Multimeric Ligands for Targeting Melanoma$626,904
R01 · FY2010 · CA
Peptide Hormone Structure Function$337,587
R01 · FY2010 · DK · contact PI
DESIGN OF NOVEL LIGANDS WITH UNIQUE BIOLOGICAL PROFILES FOR NEUROPATHIC PAIN AND$198,210
P01 · FY2010 · DA · contact PI
SYNTHESIS CORE$165,607
P01 · FY2010 · DA · contact PI
ADMINISTRATIVE CORE$82,804
P01 · FY2010 · DA · contact PI
NEW MODALITIES FOR TREATMENT OF PAIN AND DRUG ABUSE$1,244,283
P01 · FY2009 · DA · contact PI
Multimeric Ligands for Targeting Melanoma$616,331
R01 · FY2009 · CA
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$453,956
R01 · FY2009 · DA · contact PI
Peptide Hormone Structure Function$336,677
R01 · FY2009 · DK · contact PI
SYNTHESIS CORE$241,874
P01 · FY2009 · DA · contact PI
DESIGN OF NOVEL LIGANDS WITH UNIQUE BIOLOGICAL PROFILES FOR NEUROPATHIC PAIN AND$194,220
P01 · FY2009 · DA · contact PI
ADMINISTRATIVE CORE$81,137
P01 · FY2009 · DA · contact PI
Multimeric Ligands for Targeting Melanoma$636,070
R01 · FY2008 · CA
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$460,839
R01 · FY2008 · DA · contact PI
New Modalities for Treatment of Pain and Drug Abuse$1,338,501
P01 · FY2007 · DA · contact PI
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$457,548
R01 · FY2007 · DA · contact PI
Peptide Hormone Structure Function$251,989
R01 · FY2007 · DK · contact PI
Design of Novel Opiod Peptide Ligands With Unique Biological Profiles$172,341
P01 · FY2007 · DA · contact PI
Core - Synthesis Core$150,191
P01 · FY2007 · DA · contact PI
Administrative Core$71,497
P01 · FY2007 · DA · contact PI
New Modalities for Treatment of Pain and Drug Abuse$1,338,364
P01 · FY2006 · DA · contact PI
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$458,093
R01 · FY2006 · DA · contact PI
Peptide Hormone Structure Function$288,378
R01 · FY2006 · DK · contact PI
New Modalities for Treatment of Pain and Drug Abuse$1,209,428
P01 · FY2005 · DA
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$424,430
R01 · FY2005 · DA
Peptide Hormone Structure Function$284,830
R01 · FY2005 · DK
New Modalities for Treatment of Pain and Drug Abuse$128,775
P01 · FY2005 · DA
New Modalities for Treatment of Pain and Drug Abuse$1,193,205
P01 · FY2004 · DA
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$457,760
R01 · FY2004 · DA
Peptide Hormone Structure Function$265,320
R01 · FY2004 · DK
New Modalities for Treatment of Pain and Drug Abuse$1,211,770
P01 · FY2003 · DA
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$457,760
R01 · FY2003 · DA
PEPTIDE HORMONE STRUCTURE AND FUNCTION$265,225
R01 · FY2003 · DK
New Modalities for Treatment of Pain and Drug Abuse$128,350
P01 · FY2003 · DA
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$457,760
R01 · FY2002 · DA
PEPTIDE HORMONE STRUCTURE AND FUNCTION$257,625
R01 · FY2002 · DK
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$30,629
R01 · FY2002 · DA
GORDON CONFERENCE ON THE CHEMISTRY AND BIOLOGY OF PEPTID$5,000
R13 · FY2002 · RR
NEW MODALITIES FOR TREATMENT OF PAIN AND DRUG ABUSE$1,108,996
P01 · FY2001 · DA
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$365,875
R01 · FY2001 · DA
PEPTIDE HORMONE STRUCTURE AND FUNCTION$269,167
R01 · FY2001 · DK
CORE--SYNTHESIS CORE$0
P01 · FY2001 · DA
DESIGN OF OPIOID PEPTIDE LIGANDS AND RECEPTORS$0
P01 · FY2001 · DA
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN$340,875
R01 · FY2000 · DA
PEPTIDE HORMONE STRUCTURE AND FUNCTION$255,734
R01 · FY2000 · DK
GLUCAGON STRUCTURE/FUNCTION STUDIES$206,713
R01 · FY2000 · DK
CORE--SYNTHESIS CORE$104,534
P01 · FY2000 · DA
DESIGN OF OPIOID PEPTIDE LIGANDS AND RECEPTORS$104,534
P01 · FY2000 · DA
GLUCAGON STRUCTURE/FUNCTION STUDIES$6,137
R01 · FY2000 · DK